Some comments on here assume that the antibody test is an either or comparison with antigen.
Found this interview with Atomo interesting ( Oct 29 )"Sydney-based Atomo Diagnostics (ASX: AT1) has yet another feather in its cap after authorities approved its nasal swab antigen test for COVID-19 to be used by medical professionals.
Unlike most nasal swabs on the market that need to be sent to the lab for processing, the Atomo COVID-19 antigen test can be processed at the point of care with results available after 10 minutes."
So Atomo sells antigen and antibody together in cost-effective deals designed to deliver the best possible testing results.
Over time, they can package in other types of tests. General immunity tests that screen workers for some of the 40 possible applications for the technology.
- Forums
- ASX - By Stock
- AT1
- Media Update
Media Update, page-1280
-
-
- There are more pages in this discussion • 566 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $14.06M |
Open | High | Low | Value | Volume |
2.1¢ | 2.2¢ | 2.1¢ | $3.386K | 161.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 318701 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 125713 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 318701 | 0.021 |
9 | 1005888 | 0.020 |
8 | 1130840 | 0.019 |
3 | 162414 | 0.018 |
1 | 50000 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 125713 | 2 |
0.024 | 532595 | 5 |
0.025 | 379000 | 4 |
0.026 | 415954 | 3 |
0.027 | 1093000 | 3 |
Last trade - 15.58pm 23/08/2024 (20 minute delay) ? |
AT1 (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online